{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:06:17Z","timestamp":1789589177987,"version":"build-2803163510"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bcp.2019.06.007","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T10:39:11Z","timestamp":1559990351000},"page":"113551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics"],"prefix":"10.1016","volume":"173","author":[{"given":"Patrik","family":"Pr\u0161a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bet\u00fcl","family":"Karademir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6khan","family":"Bi\u00e7im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S\u00fcha","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Mahajna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Milisav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2019.06.007_b0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"Suppl 4","key":"10.1016\/j.bcp.2019.06.007_b0010","first-page":"1","article-title":"Anthracyclines in the treatment of cancer. An overview","volume":"54","author":"Hortobagyi","year":"1997","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0300-483X(02)00383-9","article-title":"Antioxidant nutrients and adriamycin toxicity","volume":"180","author":"Quiles","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2019.06.007_b0020","series-title":"Olive Oil and Mitochondrial Oxidative Stress: Studies on Adriamycin Toxicity, Physical Exercise and Ageing, Olive Oil and Health","first-page":"119","author":"Quiles","year":"2006"},{"issue":"4","key":"10.1016\/j.bcp.2019.06.007_b0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0026-895X(25)10149-1","article-title":"Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells","volume":"45","author":"Fornari","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2019.06.007_b0030","first-page":"2891","article-title":"Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells","volume":"36","author":"Momparler","year":"1976","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2019.06.007_b0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/CMAR.S47238","article-title":"Dexrazoxane for the treatment of chemotherapy-related side effects","volume":"6","author":"Langer","year":"2014","journal-title":"Cancer Manage. Res."},{"issue":"5","key":"10.1016\/j.bcp.2019.06.007_b0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrc2608","article-title":"DNA topoisomerase II and its growing repertoire of biological functions","volume":"9","author":"Nitiss","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"13","key":"10.1016\/j.bcp.2019.06.007_b0045","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM199809243391307","article-title":"Doxorubicin-induced cardiomyopathy","volume":"339","author":"Singal","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2019.06.007_b0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2016.09.009","article-title":"Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: what is missing?","volume":"168","author":"Magdy","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2019.06.007_b0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"16","key":"10.1016\/j.bcp.2019.06.007_b0060","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1016\/0006-2952(88)90303-6","article-title":"Adriamycin-induced lipid peroxidation in mitochondria and microsomes","volume":"37","author":"Griffin-Green","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2019.06.007_b0065","first-page":"313","article-title":"Increased apoptosis in the adult rat liver after a single dose of adriamycin administration","author":"Pedrycz","year":"2004","journal-title":"Ann. Univ. Mariae Curie-Sklodowska. Sectio D: Med."},{"issue":"4","key":"10.1016\/j.bcp.2019.06.007_b0070","first-page":"475","article-title":"Ultrastructural and immunohistochemical evaluation of apoptosis in foetal rat liver after adriamycin administration","volume":"49","author":"Pedrycz","year":"2005","journal-title":"Bull. Vet. Inst. Pulawy"},{"issue":"12","key":"10.1016\/j.bcp.2019.06.007_b0075","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1440-1681.2007.04717.x","article-title":"Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after doxorubicin treatment in rats","volume":"34","author":"Santos","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bcp.2019.06.007_b0080","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2019.06.007_b0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0079-6603(01)67026-0","article-title":"Cisplatin: from DNA damage to cancer chemotherapy","volume":"67","author":"Cohen","year":"2001","journal-title":"Prog. Nucl. Acid Res. Mol. Biol."},{"issue":"19","key":"10.1016\/j.bcp.2019.06.007_b0090","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"issue":"5","key":"10.1016\/j.bcp.2019.06.007_b0095","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7150\/ijbs.5.466","article-title":"Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats","volume":"5","author":"El-Sayyad","year":"2009","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0100","first-page":"315","article-title":"Differential long-term subcellular responses in heart and liver to adriamycin stress. Exogenous L-carnitine cardiac and hepatic protection","volume":"34","author":"Zeidan","year":"2002","journal-title":", J. Submicrosc. Cytol. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tox.2004.12.003","article-title":"Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats: the effects of vitamin E and catechin","volume":"209","author":"Kalender","year":"2005","journal-title":"Toxicology"},{"issue":"24\u201325","key":"10.1016\/j.bcp.2019.06.007_b0110","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1016\/j.biomaterials.2008.04.048","article-title":"Potential hepatoprotective effects of fullerenol C60 (OH) 24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas","volume":"29","author":"Injac","year":"2008","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.bcp.2019.06.007_b0115","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.3892\/mmr.2016.5017","article-title":"Protective effect of berberine on doxorubicin-induced acute hepatorenal toxicity in rats","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.etp.2009.02.066","article-title":"Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit","volume":"62","author":"Kart","year":"2010","journal-title":"Exp. Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.bcp.2019.06.007_b0125","first-page":"4049","article-title":"Protective effect of dexpanthenol against cisplatin-induced hepatotoxicity","volume":"16","author":"Bilgic","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.bcp.2019.06.007_b0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/19390211.2017.1335822","article-title":"Ameliorative effect of gallic acid in doxorubicin-induced hepatotoxicity in Wistar rats through antioxidant defense system","volume":"15","author":"Omobowale","year":"2018","journal-title":"J. Dietary Suppl."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2015.08.017","article-title":"Taurine zinc solid dispersions attenuate doxorubicin-induced hepatotoxicity and cardiotoxicity in rats","volume":"289","author":"Wang","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/CAD.0000000000000299","article-title":"Protective effects of taurine on doxorubicin-induced acute hepatotoxicity through suppression of oxidative stress and apoptotic responses","volume":"27","author":"Nagai","year":"2016","journal-title":"Anticancer Drugs"},{"issue":"2","key":"10.1016\/j.bcp.2019.06.007_b0145","first-page":"122","article-title":"Biochemical indicators of hepatotoxicity in blood serum of rats under the effect of novel 4-thiazolidinone derivatives and doxorubicin and their complexes with polyethyleneglycol-containing nanoscale polymeric carrier","volume":"87","author":"Kobylinska","year":"2015","journal-title":"Ukrainian Biochem. J."},{"issue":"2","key":"10.1016\/j.bcp.2019.06.007_b0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.phrs.2008.01.001","article-title":"Selection of agents for prevention of cisplatin-induced hepatotoxicity","volume":"57","author":"Liao","year":"2008","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.bcp.2019.06.007_b0155","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.arcmed.2007.01.007","article-title":"Protective effects of erdosteine on doxorubicin-induced hepatotoxicity in rats","volume":"38","author":"Yagmurca","year":"2007","journal-title":"Arch. Med. Res."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.15171\/jnp.2017.25","article-title":"Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patient","volume":"6","author":"Mahmoodnia","year":"2017","journal-title":"J. Nephropathol."},{"issue":"10","key":"10.1016\/j.bcp.2019.06.007_b0165","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/CAD.0b013e3283650bda","article-title":"Platinum compounds in children with cancer: toxicity and clinical management","volume":"24","author":"Ruggiero","year":"2013","journal-title":"Anticancer Drugs"},{"issue":"7","key":"10.1016\/j.bcp.2019.06.007_b0170","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1871520614666140127105809","article-title":"Anti-cancer agent-induced nephrotoxicity","volume":"14","author":"Fukasawa","year":"2014","journal-title":"Anticancer Agents Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5414\/CN109371","article-title":"Update on the nephrotoxicity of novel anticancer agents","volume":"89","author":"Nussbaum","year":"2018","journal-title":"Clin. Nephrol."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0180","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.kint.2016.06.027","article-title":"Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting System","volume":"90","author":"Jhaveri","year":"2016","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ckj\/sft135","article-title":"Nephrotoxicity of recent anti-cancer agents","volume":"7","author":"Lameire","year":"2014","journal-title":"Clin. Kidney J."},{"issue":"10","key":"10.1016\/j.bcp.2019.06.007_b0190","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2215\/CJN.02780312","article-title":"Onco-nephrology: renal toxicities of chemotherapeutic agents","volume":"7","author":"Perazella","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.bcp.2019.06.007_b0195","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/annonc\/mdv136","article-title":"Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN)","volume":"26","author":"Launay-Vacher","year":"2015","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","article-title":"An integrated view of cisplatin-induced nephrotoxicity and ototoxicity","volume":"237","author":"Karasawa","year":"2015","journal-title":"Toxicol. Lett."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2019.06.007_b0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11010-017-3162-2","article-title":"Cisplatin-induced human peripheral blood mononuclear cells' oxidative stress and nephrotoxicity in head and neck cancer patients: the influence of hydrogen peroxide","volume":"440","author":"Quintanilha","year":"2018","journal-title":"Mol. Cell Biochem."},{"issue":"11","key":"10.1016\/j.bcp.2019.06.007_b0210","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of Cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bcp.2019.06.007_b0215","doi-asserted-by":"crossref","first-page":"4048390","DOI":"10.1155\/2016\/4048390","article-title":"New therapeutic concept of NAD redox balance for cisplatin nephrotoxicity","volume":"2016","author":"Oh","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0220","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.freeradbiomed.2009.11.022","article-title":"Cannabinoid-2 receptor limits inflammation, oxidative\/nitrosative stress, and cell death in nephropathy","volume":"48","author":"Mukhopadhyay","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2019.06.007_b0225","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00280-008-0711-0","article-title":"Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care","volume":"61","author":"Launay-Vacher","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2019.06.007_b0230","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00280-010-1402-1","article-title":"Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals","volume":"67","author":"Suddek","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0235","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1081\/CNV-120018236","article-title":"Chemotherapy-induced peripheral neuropathy: nursing perspectives","volume":"21","author":"Visovsky","year":"2003","journal-title":"Cancer Invest."},{"issue":"14","key":"10.1016\/j.bcp.2019.06.007_b0240","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/S0959-8049(02)00229-0","article-title":"Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity","volume":"38","author":"Cavaletti","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bcp.2019.06.007_b0245","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.redox.2014.01.006","article-title":"Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy","volume":"2","author":"Areti","year":"2014","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): an update","volume":"82","author":"Argyriou","year":"2012","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/13543776.2016.1111872","article-title":"Taxane anticancer agents: a patent perspective","volume":"26","author":"Ojima","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0260","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF02968008","article-title":"Mechanism of taxane neurotoxicity","volume":"11","author":"Hagiwara","year":"2004","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0265","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/exnr.1995.1008","article-title":"Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol","volume":"133","author":"Cavaletti","year":"1995","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.bcp.2019.06.007_b0270","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-009-0586-0","article-title":"Paclitaxel induces axonal microtubules polar reconfiguration and impaired organelle transport: implications for the pathogenesis of paclitaxel-induced polyneuropathy","volume":"119","author":"Shemesh","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bcp.2019.06.007_b0275","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.critrevonc.2017.09.009","article-title":"The molecular genetics of chemotherapy\u2013induced peripheral neuropathy: a systematic review and meta-analysis","volume":"120","author":"Cliff","year":"2017","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"issue":"10","key":"10.1016\/j.bcp.2019.06.007_b0280","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3109\/10428194.2013.876496","article-title":"Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacy","volume":"55","author":"Gopal","year":"2014","journal-title":"Leukemia Lymphoma"},{"issue":"18","key":"10.1016\/j.bcp.2019.06.007_b0285","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2010.32.7270","article-title":"Targeted therapy with the T-cell\u2013engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival","volume":"29","author":"Topp","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0290","doi-asserted-by":"crossref","first-page":"16318","DOI":"10.1038\/s41598-018-34507-3","article-title":"Proteomic approach for understanding milder neurotoxicity of Carfilzomib against Bortezomib","volume":"8","author":"Karademir","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2019.06.007_b0295","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0960327107076885","article-title":"Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity","volume":"26","author":"Gokcimen","year":"2007","journal-title":"Hum. Exp. Toxicol."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2019.06.007_b0300","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12011-009-8377-y","article-title":"Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity","volume":"132","author":"Bulucu","year":"2009","journal-title":"Biol. Trace Elem. Res."},{"issue":"8","key":"10.1016\/j.bcp.2019.06.007_b0305","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ejca.2007.02.001","article-title":"Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients","volume":"43","author":"Sung","year":"2007","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2019.06.007_b0310","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2003.05.139","article-title":"Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy","volume":"21","author":"Pace","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.bcp.2019.06.007_b0315","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrm.2016.110","article-title":"Coenzyme A: to make it or uptake it?","volume":"17","author":"Sibon","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bcp.2019.06.007_b0320","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3325\/cmj.2016.57.180","article-title":"Antioxidants selenomethionine and D-pantethine decrease the negative side effects of doxorubicin in NL\/Ly lymphoma-bearing mice","volume":"57","author":"Panchuk","year":"2016","journal-title":"Croatian Med. J."},{"issue":"3A","key":"10.1016\/j.bcp.2019.06.007_b0325","first-page":"1391","article-title":"Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells","volume":"20","author":"Vadgama","year":"2000","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2019.06.007_b0330","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.bios.2008.10.030","article-title":"In vitro study on the individual and synergistic cytotoxicity of adriamycin and selenium nanoparticles against Bel7402 cells with a quartz crystal microbalance","volume":"24","author":"Tan","year":"2009","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.bcp.2019.06.007_b0335","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cbi.2014.01.013","article-title":"NAD(+) administration decreases doxorubicin-induced liver damage of mice by enhancing antioxidation capacity and decreasing DNA damage","volume":"212","author":"Wang","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2019.06.007_b0340","doi-asserted-by":"crossref","first-page":"4320374","DOI":"10.1155\/2016\/4320374","article-title":"Plant-derived agents for counteracting cisplatin-induced nephrotoxicity","volume":"2016","author":"Ojha","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.bcp.2019.06.007_b0345","doi-asserted-by":"crossref","DOI":"10.1177\/2050312114546924","article-title":"Natural products as potential cancer therapy enhancers: a preclinical update","volume":"2","author":"Agbarya","year":"2014","journal-title":"SAGE Open Med."},{"issue":"Suppl","key":"10.1016\/j.bcp.2019.06.007_b0350","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.semcancer.2015.02.006","article-title":"Sustained proliferation in cancer: mechanisms and novel therapeutic targets","volume":"35","author":"Feitelson","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2019.06.007_b0355","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fphar.2017.00132","article-title":"Curcumin ameliorates cisplatin-induced nephrotoxicity and potentiates its anticancer activity in SD rats: potential role of curcumin in breast cancer chemotherapy","volume":"8","author":"Kumar","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2019.06.007_b0360","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12011-014-9886-x","article-title":"Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity","volume":"157","author":"Sahin","year":"2014","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.bcp.2019.06.007_b0365","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.phrs.2016.12.037","article-title":"Curcumin: a potentially powerful tool to reverse cisplatin-induced toxicity","volume":"117","author":"Rezaee","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0370","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s13181-012-0239-x","article-title":"The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies","volume":"9","author":"Al Moundhri","year":"2013","journal-title":"J. Med. Toxicol."},{"issue":"4","key":"10.1016\/j.bcp.2019.06.007_b0375","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3109\/01480545.2014.992437","article-title":"Cisplatin hepatotoxicity mediated by mitochondrial stress","volume":"38","author":"Waseem","year":"2015","journal-title":"Drug Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0380","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/bph.13645","article-title":"The protective effect of the natural compound hesperetin against fulminant hepatitis in vivo and in vitro","volume":"174","author":"Bai","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2019.06.007_b0385","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biopha.2016.11.089","article-title":"Hesperetin protects against H2O2-triggered oxidative damage via upregulation of the Keap1-Nrf2\/HO-1 signal pathway in ARPE-19 cells","volume":"88","author":"Zhu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2019.06.007_b0390","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.biopha.2017.03.008","article-title":"The renoprotective activity of hesperetin in cisplatin induced nephrotoxicity in rats: molecular and biochemical evidence","volume":"89","author":"Kumar","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2019.06.007_b0395","first-page":"178","article-title":"Activation of sirtuin 3 by silybin attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury","volume":"8","author":"Li","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2019.06.007_b0400","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12935-015-0194-0","article-title":"Growth inhibitory and chemo-sensitization effects of naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer","volume":"15","author":"Abaza","year":"2015","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0405","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.taap.2014.02.022","article-title":"Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: possible mechanism of nephroprotection","volume":"277","author":"Sahu","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0410","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.intimp.2015.05.050","article-title":"Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1\/2-NFkappaB p65 mediated inflammation","volume":"28","author":"Karuppagounder","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0415","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/nu8030167","article-title":"Quercetin, inflammation and immunity","volume":"8","author":"Li","year":"2016","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.bcp.2019.06.007_b0420","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00280-009-1032-7","article-title":"Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1\u03b1 in tumor and normal cells","volume":"65","author":"Du","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2019.06.007_b0425","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbrc.2011.08.037","article-title":"Quercetin-induced downregulation of phospholipase D1 inhibits proliferation and invasion in U87 glioma cells","volume":"412","author":"Park","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.bcp.2019.06.007_b0430","article-title":"Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53\/Bcl-xl","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bcp.2019.06.007_b0435","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3109\/10715762.2014.945925","article-title":"Quercetin protects radiation-induced DNA damage and apoptosis in kidney and bladder tissues of rats","volume":"48","author":"Ozyurt","year":"2014","journal-title":"Free Radic. Res."},{"issue":"2","key":"10.1016\/j.bcp.2019.06.007_b0440","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/0253-7613.178834","article-title":"Enhanced therapeutic efficacy and amelioration of cisplatin-induced nephrotoxicity by quercetin in 1,2-dimethyl hydrazine-induced colon cancer in rats","volume":"48","author":"Li","year":"2016","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.bcp.2019.06.007_b0445","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1744-8069-9-53","article-title":"The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy","volume":"9","author":"Azevedo","year":"2013","journal-title":"Mol. Pain"},{"issue":"4","key":"10.1016\/j.bcp.2019.06.007_b0450","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3945\/an.114.008052","article-title":"Genistein and cancer: current status, challenges, and future directions","volume":"6","author":"Spagnuolo","year":"2015","journal-title":"Adv. Nutr."},{"issue":"12","key":"10.1016\/j.bcp.2019.06.007_b0455","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/ki.2008.409","article-title":"Genistein protects the kidney from cisplatin-induced injury","volume":"74","author":"Sung","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2019.06.007_b0460","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00557","article-title":"Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders","volume":"9","author":"Neag","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0465","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1016-8478(23)13249-3","article-title":"Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1\/2 pathway in vascular smooth muscle cells","volume":"20","author":"Cho","year":"2005","journal-title":"Mol. Cells"},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0470","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.lfs.2013.12.211","article-title":"Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase","volume":"98","author":"Li","year":"2014","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0475","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.taap.2013.08.008","article-title":"Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth","volume":"272","author":"Hsu","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2019.06.007_b0480","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.fct.2013.09.003","article-title":"Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative\/nitrosative stress, inflammation, autophagy and apoptosis","volume":"62","author":"Domitrovic","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bcp.2019.06.007_b0485","article-title":"Study of nuclear factor-2 erythroid related factor-2 activator, berberine, in paclitaxel induced peripheral neuropathy pain model in rats","author":"Singh","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2019.06.007_b0490","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1163\/156856299X00621","article-title":"Gelatin-derived bioadhesives for closing skin wounds: an in vivo study","volume":"10","author":"Sung","year":"1999","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"5","key":"10.1016\/j.bcp.2019.06.007_b0495","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1163\/156856203766652084","article-title":"A genipin-crosslinked gelatin membrane as wound-dressing material: in vitro and in vivo studies","volume":"14","author":"Chang","year":"2003","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"6","key":"10.1016\/j.bcp.2019.06.007_b0500","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cmet.2006.04.010","article-title":"Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced beta cell dysfunction in isolated pancreatic islets","volume":"3","author":"Zhang","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2019.06.007_b0505","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.biopha.2017.07.018","article-title":"Genipin attenuates cisplatin-induced nephrotoxicity by counteracting oxidative stress, inflammation, and apoptosis","volume":"93","author":"Mahgoub","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2019.06.007_b0510","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.etap.2017.02.014","article-title":"Sinapic acid ameliorate cadmium-induced nephrotoxicity: in vivo possible involvement of oxidative stress, apoptosis, and inflammation via NF-kappaB downregulation","volume":"51","author":"Ansari","year":"2017","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.bcp.2019.06.007_b0515","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.biopha.2017.06.085","article-title":"Sinapic acid modulates Nrf2\/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats","volume":"93","author":"Ansari","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0520","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.108.147181","article-title":"Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative\/nitrosative stress, inflammation, and cell death","volume":"328","author":"Pan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0525","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bph.12439","article-title":"Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy","volume":"171","author":"Ward","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2019.06.007_b0530","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.391","article-title":"Dioscin induces prostate cancer cell apoptosis through activation of estrogen receptor-\u03b2","volume":"8","author":"Tao","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2019.06.007_b0535","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2017.01.007","article-title":"Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation","volume":"378","author":"Zhang","year":"2017","journal-title":"Toxicology"},{"issue":"15","key":"10.1016\/j.bcp.2019.06.007_b0540","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/bph.13862","article-title":"Protective effects of dioscin against cisplatin-induced nephrotoxicity via the microRNA-34a\/sirtuin 1 signalling pathway","volume":"174","author":"Zhang","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2019.06.007_b0545","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2017.01.009","article-title":"Tomato and lycopene supplementation and cardiovascular risk factors: a systematic review and meta-analysis","volume":"257","author":"Cheng","year":"2017","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.bcp.2019.06.007_b0550","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/pcan.2017.25","article-title":"Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis","volume":"20","author":"Rowles","year":"2017","journal-title":"Prostate Cancer Prostatic. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0555","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1472-6882-12-124","article-title":"Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats","volume":"12","author":"Lee","year":"2012","journal-title":"BMC Complementary Alternative Med."},{"key":"10.1016\/j.bcp.2019.06.007_b0560","unstructured":"W.H. Organization, WHO model list of essential medicines, 20th list (March 2017, amended August 2017), (2017)."},{"issue":"4","key":"10.1016\/j.bcp.2019.06.007_b0565","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/14734220601142878","article-title":"N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology","volume":"6","author":"Arakawa","year":"2007","journal-title":"Cerebellum"},{"issue":"12","key":"10.1016\/j.bcp.2019.06.007_b0570","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.3390\/molecules23123305","article-title":"Overview on the effects of N-acetylcysteine in neurodegenerative diseases","volume":"23","author":"Tardiolo","year":"2018","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bcp.2019.06.007_b0575","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/cbf.1707","article-title":"N-acetylcysteine modulates doxorubicin-induced oxidative stress and antioxidant vitamin concentrations in liver of rats","volume":"28","author":"Ko\u00e7kar","year":"2010","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bcp.2019.06.007_b0580","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/689639","article-title":"Vitamin e and N-acetylcysteine as antioxidant adjuvant therapy in children with acute lymphoblastic leukemia","volume":"2009","author":"Al-Tonbary","year":"2009","journal-title":"Adv. Hematol."},{"issue":"8","key":"10.1016\/j.bcp.2019.06.007_b0585","first-page":"2929","article-title":"Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma","volume":"26","author":"Grisanti","year":"2018","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.bcp.2019.06.007_b0590","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12885-016-2182-8","article-title":"Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study","volume":"16","author":"Ratzon","year":"2016","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2019.06.007_b0595","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3748\/wjg.v12.i2.259","article-title":"Antioxidative effect of melatonin, ascorbic acid and N-acetylcysteine on caerulein-induced pancreatitis and associated liver injury in rats","volume":"12","author":"E\u015frefo\u011flu","year":"2006","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"20","key":"10.1016\/j.bcp.2019.06.007_b0600","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1158\/0008-5472.CAN-06-1776","article-title":"Melatonin in cancer management: progress and promise","volume":"66","author":"Jung","year":"2006","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2019.06.007_b0605","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-005-9003-8","article-title":"Effects of melatonin in reducing the toxic effects of doxorubicin","volume":"286","author":"\u00d6z","year":"2006","journal-title":"Mol. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.bcp.2019.06.007_b0610","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3748\/wjg.v16.i12.1473","article-title":"Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines","volume":"16","author":"Fan","year":"2010","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.bcp.2019.06.007_b0615","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1635361","article-title":"Comparative study of the antioxidant effects of metformin, glibenclamide, and repaglinide in alloxan-induced diabetic rats","volume":"2016","author":"Chukwunonso Obi","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"9","key":"10.1016\/j.bcp.2019.06.007_b0620","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/17425255.2018.1513492","article-title":"The protective role of melatonin in chemotherapy-induced nephrotoxicity: a systematic review of non-clinical studies","volume":"14","author":"Haghi-Aminjan","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0625","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3892\/br.2015.547","article-title":"Comparison of the effects of melatonin and genistein on radiation-induced nephrotoxicity: results of an experimental study","volume":"4","author":"Canyilmaz","year":"2016","journal-title":"Biomed. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0630","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0955-2863(94)90082-5","article-title":"Biochemical effects of lipids on cancer therapy","volume":"5","author":"Burns","year":"1994","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0635","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0167-4889(86)90064-9","article-title":"Adriamycin transport and sensitivity in fatty acid-modified leukemia cells","volume":"888","author":"Burns","year":"1986","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"issue":"7","key":"10.1016\/j.bcp.2019.06.007_b0640","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/0748233713483203","article-title":"The protective effects of \u03c9-3 fatty acids on doxorubicin-induced hepatotoxicity and nephrotoxicity in rats","volume":"31","author":"Tulubas","year":"2015","journal-title":"Toxicol. Ind. Health"},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0645","first-page":"165","article-title":"Effect of simvastatin on cisplatin-induced nephrotoxicity in male rats, Iranian","volume":"7","author":"Khoshnoud","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2019.06.007_b0650","first-page":"273","article-title":"Protective effect of pravastatin on doxorubicin-induced hepatotoxicity","volume":"118","author":"Mansouri","year":"2017","journal-title":"Bratisl. Lek. Listy"},{"issue":"25","key":"10.1016\/j.bcp.2019.06.007_b0655","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.2217\/fon-2018-0210","article-title":"Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling","volume":"14","author":"Reichardt","year":"2018","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0660","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/annonc\/mdl413","article-title":"Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies","volume":"18","author":"Mouridsen","year":"2006","journal-title":"Ann. Oncol."},{"issue":"22","key":"10.1016\/j.bcp.2019.06.007_b0665","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1021\/jm990144s","article-title":"C60 and water-soluble fullerene derivatives as antioxidants against radical-initiated lipid peroxidation","volume":"42","author":"Wang","year":"1999","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2019.06.007_b0670","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.niox.2004.08.003","article-title":"Nitric oxide-scavenging activity of polyhydroxylated fullerenol, C60 (OH) 24","volume":"11","author":"Mirkov","year":"2004","journal-title":"Nitric Oxide"},{"issue":"4","key":"10.1016\/j.bcp.2019.06.007_b0675","first-page":"806","article-title":"Antioxidant properties and hypothetic radical mechanism of fullerenol C60 (OH) 24","volume":"27","author":"Djordjevic","year":"2004","journal-title":"Oxid. Commun."},{"key":"10.1016\/j.bcp.2019.06.007_b0680","series-title":"Materials Science Forum","first-page":"549","article-title":"Radioprotective efficiency of fullerenol in irradiated mice","author":"Trajkovi\u0107","year":"2005"},{"issue":"1","key":"10.1016\/j.bcp.2019.06.007_b0685","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.colsurfb.2007.01.005","article-title":"Tissue-protective effects of fullerenol C60 (OH) 24 and amifostine in irradiated rats","volume":"58","author":"Trajkovi\u0107","year":"2007","journal-title":"Colloids Surf., B"},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0690","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00045391-200205000-00008","article-title":"Analgesics and glutathione","volume":"9","author":"Lauterburg","year":"2002","journal-title":"Am. J. Ther."},{"issue":"8","key":"10.1016\/j.bcp.2019.06.007_b0695","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3109\/00498259109039546","article-title":"Glutathione depletion: its effects on other antioxidant systems and hepatocellular damage","volume":"21","author":"Comporti","year":"1991","journal-title":"Xenobiotica"},{"issue":"6","key":"10.1016\/j.bcp.2019.06.007_b0700","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.biomaterials.2008.10.060","article-title":"Protective effects of fullerenol C60 (OH) 24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer","volume":"30","author":"Injac","year":"2009","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.bcp.2019.06.007_b0705","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1096\/fj.13-235440","article-title":"Unexpected low-dose toxicity of the universal solvent DMSO","volume":"28","author":"Galvao","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2019.06.007_b0710","first-page":"S146","article-title":"Protective effects of fullerenol C60 (OH) 24 on doxorubicin-induced hepatotoxicity in rats: pathohistological study","volume":"172","author":"Jacevic","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2019.06.007_b0715","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cbi.2014.01.013","article-title":"NAD+ administration decreases doxorubicin-induced liver damage of mice by enhancing antioxidation capacity and decreasing DNA damage","volume":"212","author":"Wang","year":"2014","journal-title":"Chem. Biol. Interact."},{"issue":"9","key":"10.1016\/j.bcp.2019.06.007_b0720","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/17425255.2018.1513492","article-title":"The protective role of melatonin in chemotherapy-induced nephrotoxicity: a review of non-clinical studies","volume":"14","author":"Haghi-Aminjan","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"11","key":"10.1016\/j.bcp.2019.06.007_b0725","first-page":"1769","article-title":"The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial","volume":"19","author":"Kottschade","year":"2011","journal-title":"Support. Care Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2019.06.007_b0730","first-page":"484","article-title":"N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data","volume":"14","author":"Lin","year":"2006","journal-title":"Support. Care Cancer"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219302266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219302266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:08:35Z","timestamp":1757768915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219302266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":146,"alternative-id":["S0006295219302266"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.06.007","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113551"}}